Natalie Healey

Freelance health and science journalist, she is the former head of editorial at Patient.

How Covid-19 rocked rare disease communities

Big pharma drug prices

Does big pharma’s R&D justify high drug prices?

A coloured scanning electron micrograph of ovarian cancer cells

Ovarian cancer screening disappoints, but lessons remain

The challenges facing the NHS during COVID and beyond

Global Business

The real dangers of vaccine hesitancy

Cancer inequalities

Where you live shouldn’t impact your cancer care

PTSD fears for frontline workers post-pandemic

UK sperm shortage

How to solve Britain’s sperm donor crisis

More Articles